Letter to the editor: Using angiotensin-converting enzyme inhibitors to prevent liver-related events in NAFLD-Revisiting the renin-angiotensin-aldosterone system pathways.
Manas Kumar PanigrahiPrajna AnirvanPublished in: Hepatology (Baltimore, Md.) (2022)